Lignans
DBCAT000416Pharmacologic class
A class of dibenzylbutane derivatives which occurs in higher plants and in fluids (bile, serum, urine, etc.) in man and other animals. These compounds, which have a potential anti-cancer role, can be synthesized in vitro... A DrugBank category of 5 drugs. 1 of them is approved.
- Also known as
- Neolignans
What you can answer from here — as of August 24, 2016
Which targets do Lignans share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account